Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/2/2020
MSD Secures Chinese Approval of HIV Drug Pifeltro (Doravirine)
12/2/2020
Beijing Strengthens Medical Ethics Review with Mutual Recognition Alli...
12/2/2020
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
12/2/2020
Etherna and China Grand Pharma Set Up Joint Venture to Tap into mRNA V...
12/1/2020
China Initiates Mutual Access Program for Biotech Investors in Hong Ko...
12/1/2020
Cedilla and HitGen Announce Research Deal on DNA-Encoded Library Base...
12/1/2020
Helsinn and Kyowa Kirin AP Sign Deal for MF-CTCL Topical Drug Valchlo...
12/1/2020
NMPA and ANVISA Sign MoU on Cooperation
12/1/2020
LianBio Cleared for Phase 2a Trial of Anticancer Infigratinib in China
12/1/2020
Mind The Gap - The IP Protection Law vs. Reality in China
12/1/2020
MNCs Renew Commitments at CIIE as China Pushes Telemedicine and Specia...
11/30/2020
China's New Export Control Law Triggers More Trade and Investment Comp...
11/30/2020
Junshi Biosciences Announces NMPA Acceptance of Its IND for JS006
11/29/2020
Ascentage In-licenses UM's MDM2 Degrader Developed Using PROTAC Tech...
11/29/2020
CDE Issues the Guidelines for Use of GnRH Stimulants in Clinical Trial...
11/29/2020
CDE Issues the Technical Guidelines for Clinical Trial Endpoints for L...
11/27/2020
Financial-related Company News in Brief
11/27/2020
CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
11/27/2020
Xbiome Raises Over $14M in Series B Financing
11/27/2020
Recent Official and Executive Moves
11/26/2020
China Issues the Working Plan for Innovative Development of Drug and M...
11/26/2020
NMPA and Chinese Customs Announce Addition of Two Drug Import Destinat...
11/25/2020
CDE Issues the CDE Guidelines for Management of Supplemental Informati...
11/25/2020
Sales Expenditure Far Exceeds R&D Spending at A Share-listed Medpharm ...
11/25/2020
Performance Snapshot of A Share-Listed Chinese MedPharm Cos in 3Qs/202...
11/25/2020
NHSA Makes Advances on National Medical Insurance IT Infrastructural B...
11/25/2020
Snapshot of BMI System Financial Performance in 3Qs/2020
11/25/2020
Snapshot of MNC China Performance in 3Qs/2020 and New Product Launch P...
11/25/2020
Sinopharm Seeking Chinese Approval for COVID-19 Vaccine
11/25/2020
Antengene Granted Chinese Approval for Phase I/II Trial of ATG-016 (El...
Page:
154
/
719
Total number of articles:
21555
:
[First]
[<<]
[152]
[153]
[154]
[155]
[156]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit